Literature DB >> 35772404

The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis.

Eunus S Ali1, Anna Lipońska2, Brendan P O'Hara1, David R Amici1, Michael D Torno1, Peng Gao3, John M Asara4, Mee-Ngan F Yap2, Marc L Mendillo1, Issam Ben-Sahra5.   

Abstract

Bicarbonate (HCO3-) ions maintain pH homeostasis in eukaryotic cells and serve as a carbonyl donor to support cellular metabolism. However, whether the abundance of HCO3- is regulated or harnessed to promote cell growth is unknown. The mechanistic target of rapamycin complex 1 (mTORC1) adjusts cellular metabolism to support biomass production and cell growth. We find that mTORC1 stimulates the intracellular transport of HCO3- to promote nucleotide synthesis through the selective translational regulation of the sodium bicarbonate cotransporter SLC4A7. Downstream of mTORC1, SLC4A7 mRNA translation required the S6K-dependent phosphorylation of the translation factor eIF4B. In mTORC1-driven cells, loss of SLC4A7 resulted in reduced cell and tumor growth and decreased flux through de novo purine and pyrimidine synthesis in human cells and tumors without altering the intracellular pH. Thus, mTORC1 signaling, through the control of SLC4A7 expression, harnesses environmental bicarbonate to promote anabolic metabolism, cell biomass, and growth.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SLC4A7/NBCn1; bicarbonate metabolism; mTOR signaling; purine metabolism; pyrimidine metabolism

Mesh:

Substances:

Year:  2022        PMID: 35772404      PMCID: PMC9444906          DOI: 10.1016/j.molcel.2022.06.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  70 in total

1.  mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.

Authors:  Issam Ben-Sahra; Gerta Hoxhaj; Stéphane J H Ricoult; John M Asara; Brendan D Manning
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

2.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2021-04-15       Impact factor: 41.582

Review 3.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

Review 5.  Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

Authors:  Katharine A White; Bree K Grillo-Hill; Diane L Barber
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

6.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

7.  A unifying model for mTORC1-mediated regulation of mRNA translation.

Authors:  Carson C Thoreen; Lynne Chantranupong; Heather R Keys; Tim Wang; Nathanael S Gray; David M Sabatini
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

8.  Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival.

Authors:  Nicolai J Toft; Trine V Axelsen; Helene L Pedersen; Marco Mele; Mark Burton; Eva Balling; Tonje Johansen; Mads Thomassen; Peer M Christiansen; Ebbe Boedtkjer
Journal:  Elife       Date:  2021-07-05       Impact factor: 8.140

Review 9.  Fundamentals of cancer metabolism.

Authors:  Ralph J DeBerardinis; Navdeep S Chandel
Journal:  Sci Adv       Date:  2016-05-27       Impact factor: 14.136

10.  Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.

Authors:  Craig Ramirez; Andrew D Hauser; Emily A Vucic; Dafna Bar-Sagi
Journal:  Nature       Date:  2019-12-11       Impact factor: 49.962

View more
  1 in total

Review 1.  Recent advances and limitations of mTOR inhibitors in the treatment of cancer.

Authors:  Eunus S Ali; Kangkana Mitra; Shamima Akter; Sarker Ramproshad; Banani Mondal; Ishaq N Khan; Muhammad Torequl Islam; Javad Sharifi-Rad; Daniela Calina; William C Cho
Journal:  Cancer Cell Int       Date:  2022-09-15       Impact factor: 6.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.